FDA: Serious Liver Injury Being Observed in Patients Without Cirrhosis Taking Ocaliva (Obeticholic Acid) to Treat Primary Biliary Cholangitis
FDA:在没有肝硬化的患者中观察到严重肝损伤,使用Ocaliva(奥贝胆酸)治疗原发性胆汁性胆管炎
FDA: Serious Liver Injury Being Observed in Patients Without Cirrhosis Taking Ocaliva (Obeticholic Acid) to Treat Primary Biliary Cholangitis
FDA:在没有肝硬化的患者中观察到严重肝损伤,使用Ocaliva(奥贝胆酸)治疗原发性胆汁性胆管炎
使用浏览器的分享功能,分享给你的好友吧